Latest Earnings Results: Q2 '26
Estimated EPS
$1.85
Reported EPS
$1.87
Surprise
+0.95%
Estimated Rev
$2.5B
Reported Rev
$2.47B
Surprise
-1.34%
• Reported GAAP EPS of $1.65 up 2.48% YoY • Reported revenue of $2.47B up 0.33% YoY • Zoetis revised its full year 2026 revenue guidance to $9.120 billion to $9.320 billion, with adjusted net income organic operational growth of (9)% to (5)% and adjusted diluted EPS of $6.15-$6.25.
Bullish Takeaway
Zoetis benefited from strong livestock performance in both U.S. and international segments, while the company continued to advance its innovation pipeline and expand diagnostics capabilities through strategic acquisitions and product approvals.
Bearish Takeaway
Zoetis faced a pressured U.S. companion animal market, characterized by softer end-market demand, increased price sensitivity, and heightened competitive pressure from generic alternatives, resulting in a 7% decline in U.S. revenue.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $1.60 | -- | -- | N/A |
Q2 '26 | $1.85 | $1.87 | 0.95% | BEAT |
Q1 '26 | $1.60 | $1.53 | -4.60% | MISSED |
Q4 '25 | $1.40 | $1.48 | 5.52% | BEAT |
Q3 '25 | $1.62 | $1.70 | 4.88% | BEAT |